THERESON S.p.A., an Italian company which has developed an innovative and clinically effective medical device technology for the treatment of diabetic foot ulcers, has successfully completed a financing round, raising about € 1 million from a number of private investors, including managers and entrepreneurs adding to the existing shareholding significant experience and network in the health-care space.
360 Capital Partners, a Venture Capital fund already backing THERESON, also participated in the round of funding. Including the proceeds of this last round, the overall amount of funds raised by THERESON since its start-up in 2011 is about € 4,5 million.
Here you can find more details on the investment round.